Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia

Schizophrenia Research

Volumn 100, Issue 1-3, 2008, Pages 261-269

  AhnAllen, Christopher G ^a   Nestor, Paul G ^b,c   Shenton, Martha E ^c   McCarley, Robert W ^c   Niznikiewicz, Margaret A ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Attention; Cognition; Nicotine; Schizophrenia; Smoking; Withdrawal

Indexed keywords

NICOTINE; NICOTINE PATCH;

ACCURACY; ALERTNESS; ARTICLE; CIGARETTE SMOKING; COGNITION; DRUG EFFECT; MENTAL FUNCTION; MENTAL PERFORMANCE; ORIENTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPONSE TIME; SCHIZOPHRENIA; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ATTENTION; COGNITION DISORDERS; COMORBIDITY; CONTROL GROUPS; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SKIN ABSORPTION; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 40149097771     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.07.030     Document Type: Article

References (49)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) (1981), University of Iowa, Iowa City
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) (1984), University of Iowa, Iowa City
3. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in the anterior cingulate cortex. Trends in Cognitive Sciences 4 (2000) 215-222
4. Chong S.-A., Tan E.-C., Tan C.H., and Mythily M.B. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene. Journal of Psychiatry & Neuroscience 28 (2003) 185-189
5. Chou K.-R., Chen R., Lee J.-F., Ku C.-H., and Lu R.-B. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies 41 (2004) 321-330
6. Corbetta M., Kincade J.M., Ollinger J.M., McAvoy M.P., and Shulman G. Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nature Neuroscience 3 (2000) 292-297
7. Coull J.T., Frith C.D., Frackowiak R.S., and Grasby P.M. A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia 34 11 (1996) 1085-1095
8. Dalack G.W., Healy D.J., and Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 155 (1998) 1490-1501
9. de Leon J., Tracy J., McCann E., and McGrory A. Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophrenia Research 57 (2002) 293-301
10. Dhar P. Measuring tobacco smoke exposure: Quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. Journal of Pharmaceutical and Biomedical Analysis 35 (2004) 155-168
11. Durany N., Zöchling R., Boissl K.W., Paulus W., Ransmayr G., Tatschner T., et al. Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neuroscience Letters 287 (2000) 109-112
12. Eriksen B.A., and Eriksen C.W. Effects of noise letters upon the identification of a target letter in a nonsearch task. Perception & Psychophysics 16 (1974) 143-149
13. Fan J., McCandliss B.D., Sommer T., Raz A., and Posner M.I. Testing the efficiency and independence of attentional networks. Journal of Cognitive Neuroscience 14 (2002) 340-347
14. Fan J., McCandliss B.D., Fossella J., Flombaum J.I., and Posner M.I. The activation of attentional networks. NeuroImage 26 (2005) 471-479
15. Fant R.V., Owen L.L., and Henningfield J.E. Nicotine replacement therapy. Primary Care 26 (1999) 633-652
16. Fioravanti M., Carlone O., Vitale B., Cinti M.E., and Clare L. A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychology Review 15 (2005) 73-95
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (1997), American Psychiatric Press, Washington, DC
18. Freedman R., Hall M., Adler L.E., and Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biological Psychiatry 38 (1995) 22-33
19. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper T., et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26 (2001) 75-85
20. Glassman A.H. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 150 (1993) 546-553
21. Gooding D.C., Braun J.G., and Studer J.A. Attentional network task performance in patients with schizophrenia-spectrum disorders: evidence of a specific deficit. Schizophrenia Research 88 (2006) 169-178
22. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.-O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86 (1991) 1119-1127
23. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., and Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biological Psychiatry 55 (2004) 850-858
24. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
25. Kleykamp B., Jennings J., Sams C., Shaffer D., Austin J., Gray J., et al. The effects of smoking-related stimuli on cognitive performance. Paper presented at the meeting of the Society for Research on Nicotine and Tobacco, Austin, TX (2007) February
26. Kumari V., Gray J.A., ffytche D.H., Mitterschiffthaler M.T., Das M., Zachariah E., et al. Cognitive effects of nicotine in humans: an fMRI study. NeuroImage 19 (2003) 1002-1013
27. Lawrence N.S., Ross T.J., and Stein E.A. Cognitive mechanisms of nicotine on visual attention. Neuron 36 (2002) 539-548
28. Leonard S., Gault J., Adams C., Breese C.R., Rollins Y., Adler L.E., et al. Nicotinic receptors, smoking and schizophrenia. Restorative Neurology and Neuroscience 12 (1998) 195-201
29. Leonard S., Breese C., Adams C., Benhammou K., Gault J., Stevens K., et al. Smoking and schizophrenia: abnormal nicotinic receptor expression. European Journal of Pharmacology 30 (2000) 237-242
30. Levin E.D., Wilson W., Rose J., and McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenia. Neuropsychopharmacology 15 (1996) 429-436
31. Lichtermann D., Jesper E., Eero P., Tanskanen A., and Lönnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry 58 (2001) 573-578
32. Marrocco R.T., Witte E.A., and Davidson M.C. Arousal systems. Current Opinion in Neurobiology 4 (1994) 166-170
33. McCloughen A. The association between schizophrenia and cigarette smoking: a review of the literature and implications for mental health nursing practice. International Journal of Mental Health Nursing 12 (2003) 119-129
34. Nestor P.G., Han S.D., Niznikiewicz M., Salisbury D., Spencer K., Shenton M.E., et al. Semantic disturbance in schizophrenia and its relationship to the cognitive neuroscience of attention. Biological Psychology 57 (2001) 23-46
35. Nestor P.G., Kubicki M., Spencer K.M., Niznikiewicz M., McCarley R.W., and Shenton M.E. Attentional networks and cingulum bundle in chronic schizophrenia. Schizophrenia Research 90 (2007) 308-315
36. Neuhaus A.H., Koehler S., Opgen-Rhein C., Urbanek C., Hahn E., and Dettling M. Selective anterior cingulated cortex deficit during conflict solution in schizophrenia: An event-related potential study. Journal of Psychiatry Research 41 (2007) 635-644
37. Osby U., Correia N., Brandt L., Ekbom A., and Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research 45 (2000) 21-28
38. Posner M.I. Orienting of attention. Quarterly Journal of Experimental Psychology 32 (1980) 3-25
39. Posner M.I., and DiGirolamo F.J. Executive attention: conflict, target detection and cognitive control. In: Parasuraman R. (Ed). The attentive brain (1998), MIT Press, Cambridge, MA
40. Rose J.E., Levin E.D., and Benowitz N. Saliva nicotine as an index of plasma levels in nicotine skin patch users. Therapeutic Drug Monitoring 15 (1993) 431-435
41. Rafal R.D., and Posner M.I. Deficits in human visual spatial attention following thalamic lesions. Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 7349-7353
42. Sacco KA., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 62 (2005) 649-659
43. Smith R.C., Warner-Cohen J., Matute M., Butler E., Kelly E., Vaidhyanathaswamy S., et al. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31 (2006) 637-643
44. Stevens J. Intermediate Statistics. 2nd ed. (1999), Lawrence Erlbaum Associates, London
45. Strand J.E., and Nyback H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. European Psychiatry 20 (2005) 50-54
46. Tidey J.W., Rohsenow D.J., Kaplan G.B., and Swift R.M. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug and Alcohol Dependence 7 (2005) 421-429
47. Wang K., Fan J., Dong Y., Wang C., Lee T.M.C., and Posner M.I. Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophrenia Research 78 (2005) 235-241
48. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. (1997), The Psychological Corporation, San Antonio, TX
49. Williams J.M., Ziedonis D.M., Abanyie F., Steinberg M.L., Foulds J., and Benowitz N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorders is not a metabolic effect. Schizophrenia Research 79 (2005) 323-335